Atlas Trials

Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations

Clinical trial NCT04765839 · COMPLETED

Trial details

NCT number
NCT04765839
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Vaccine Preventable Disease
Start date
2021-02-12
Primary completion
2021-04-03
Enrollment
74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.